Zurueck zur Suche

Reporte zur Charge N34CK

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MN 2 MI 2 TX 2 MA 1 IA 1 FL 1 NC 1

VAERS 1955033

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

kritisch
Staat
MN
Alter
38,0
Geschlecht
F
Eingang
16.12.2021
Impfdatum
08.11.2021
Beginn
10.11.2021
Tage bis Beginn
2,0
Dosis
N/A
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Cardiac disorder Computerised tomogram abnormal Deep vein thrombosis Dyspnoea Muscle spasms Pain in extremity Pulmonary embolism Thrombosis Ultrasound scan abnormal

Symptomtext

Within a few days of the shot, I started experiencing leg cramping and a week later, extreme pain in my right calf and behind the knee. I went into the doctor on 11/19/21, and was diagnosed with multiple blood clots in my lower right leg. These were confirmed with an ultrasound. Three days later, on 11/22, I went to the ER with shortness of breath and irregular heart activity - I was diagnosed with multiple pulmonary embolisms in both lungs. Treatment recommended was anticoagulants and home monitoring, currently one month into recovery.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
11/19/21: Ultrasound - confirmed DVTs 11/22/21: CAT scan with contrast - confirmed Pulmonary Embolism
Aktuelle Erkrankungen
None
Vorgeschichte
Factor V Leiden; heterozygous.
Andere Medikamente
Zyrtec; Famotidine.
Allergien
None
Vorherige Impfungen
Two weeks after shot #2 of the Moderna series, I had a swollen lower left calf for a week. Age 38 at date of vaccine. Moderna on

VAERS 1865506

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34ck

schwer
Staat
MA
Alter
11,0
Geschlecht
M
Eingang
12.11.2021
Impfdatum
11.11.2021
Beginn
11.11.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Immediate post-injection reaction Loss of consciousness Seizure Syncope

Symptomtext

Patient fainted immediately after receiving full vaccination and then started seizure on ground for approximately 3-5 seconds before awakening

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2537875

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

moderat
Staat
MI
Alter
50,0
Geschlecht
M
Eingang
20.12.2022
Impfdatum
06.12.2021
Beginn
11.12.2022
Tage bis Beginn
370,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Alanine aminotransferase increased Aspartate aminotransferase increased Asthenia Blood sodium decreased COVID-19 Chest X-ray normal Diarrhoea Fatigue Hyperkalaemia Hypocalcaemia Hypomagnesaemia Hyponatraemia Hypotension Mineral supplementation SARS-CoV-2 test positive

Symptomtext

Discharge Provider: PRIVATE, MD Primary Care Provider: PRIVATE, DO Admission Date: 12/11/2022 Discharge Date: Dec 16, 2022 COVID positive Date: 12/11/2022 PRESENTING PROBLEM: Hyponatremia [E87.1] Hypotension, unspecified hypotension type [I95.9] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 51-year-old male with history of type 2 diabetes mellitus, hypothyroidism and hyperlipidemia who presented with generalized weakness and fatigue for 2-3 days. In the emergency department, he had mild hypotension. Labs were significant for sodium of 125, AST 66 an ALT of 72. He tested positive for COVID-19. Chest x-ray was unremarkable. He was given 2 L of normal saline and admitted to the hospitalist service for further care. Upon admit was continued on IV normal saline. He did develop hyperkalemia, hypomagnesemia and hypocalcemia. His hyperkalemia improved without intervention, but he was supplemented with IV calcium and magnesium with improvement. His sodium levels improved with normal saline infusion and rehydration. He had ongoing diarrhea, which was treated symptomatically with Imodium. This was felt to be secondary to COVID-19 infection. He had minimal respiratory symptoms, and remained stable on room air. He did not meet criteria for treatment with IV remdesivir or oral Decadron. Pt on day of discharge reports feeling well. Diarrhea resolved and he has been tolerating PO foods >48 hrs. Discharged on 12/16 with sodium tabs x3 d. Will have follow up with PCP in 1 week.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypotension
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Fatty liver Senile nuclear cataract, bilateral Choroidal nevus, left eye Hypothyroidism Diabetes mellitus type 2 without retinopathy (HCC) DM type 2 with diabetic dyslipidemia (HCC) Insulin dependent type 2 diabetes mellitus, controlled (HCC) Hyponatremia Family hx of prostate cancer Myopia of both eyes
Andere Medikamente
cetirizine (ZYRTEC) 10 MG tablet Continuous Blood Gluc Sensor (FREESTYLE LIBRE 14 DAY SENSOR) MISC insulin degludec (TRESIBA FLEXTOUCH) 100 UNIT/ML pen-injector insulin lispro (HUMALOG KWIKPEN) 100 UNIT/ML pen-injector Insulin Pen Needle (B
Allergien
Azithromycin Erythromycin
Vorherige Impfungen
-

VAERS 1865117

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

moderat
Staat
IA
Alter
41,0
Geschlecht
F
Eingang
12.11.2021
Impfdatum
09.11.2021
Beginn
09.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Product administered at inappropriate site

Symptomtext

The patient received her flu shot on Tuesday 11/9 and stated that it was injected high up in there shoulder bone. Patient stated that she was unable to move her arm and that she has lost some range of motion. Patient stated that the injection was given 1-2mm below the bone and that it should have been given lower. The patient stated that she experienced muscle soreness and lost the ability to move her arm after receiving the flu shot. She reports current limited range of motion and is unable to lift items.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1897091

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

mild
Staat
MI
Alter
19,0
Geschlecht
F
Eingang
24.11.2021
Impfdatum
20.11.2021
Beginn
20.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Angioedema Chills Lip swelling Neck pain Pain Pharyngeal swelling Pyrexia Swelling face

Symptomtext

Patient reported swelling of face and throat - top lip swollen very significantly. (Dx: Angioedema) Went to ED same day as vaccinations administered. (influenza and COVID booster dose) Hospital Emergency; 11/20/2021 CHIEF COMPLAINT: POSSIBLE ALLERGIC REACTION (Had Flu shot and Pfizer booster shot today, now having swelling to upper lip worsening. Took tylenol at 2215. Was having neck pain and chills - resolved with tylenol. ) DIAGNOSIS at time of disposition: 1. Angioedema, initial encounter Follow-up Information Call, MD. Specialty: Family Medicine ED Course as of 11/21/21 0151 Sun Nov 21, 2021 0137 Patient is a very pleasant 19-year-old female that presents emergency department with swelling to her upper lip that she noticed about 40 minutes prior to arrival. She states she received her Pfizer booster and her influenza vaccine around 11:00 a.m., just after 10:00 p.m. she began developed some subjective fevers chills and body ache and neck ache and noticed swelling to her upper lip. The Tylenol resolved all the symptoms except her lip and thus she presented to the emergency department for evaluation. She denies any tongue swelling, no feeling her throat closing, no difficulty swallowing or breathing. On exam she had mild upper lip swelling but thankfully the rest of her exam was reassuring. She states her lips felt pruritic but she had no evidence of urticaria on exam. An IV was started, the patient was provided Solu-Medrol, Pepcid, Benadryl and monitored closely for the last nearly 3 hours duration. The patient was checked several times, the most recent of which showed improvement of her lip swelling (although not full resolution). Thankfully she is well-appearing and not showing evidence of anaphylaxis. She has had no new symptoms or worsening symptoms. Plan is for the patient to be able to go at the 3 hour mark. I have written her for Prednisone for home for the next 5 days, and discussed use of OTC Benadryl and Pepcid for the next 5 days. I have advised her that she should likely not receive any additional Pfizer COVID vaccine or the standard flu vaccine in the future. We also discussed emergency department return precautions including a worsening of her lip swelling, swelling to her tongue, the feeling of swelling to her throat, difficulty breathing, or difficulty swallowing. The patient verbalized understanding instructions all questions were answered. She and her mother were agreeable with the plan of care discharged home. [EC] 0150 Patient has been in the emergency department for 3 hours, continues to be doing well and to be discharged as previously discussed. [EC]

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NA
Vorgeschichte
Viral wart Acne vulgaris Nexplanon in place Chronic hip pain, right Gluteal tendinitis, right hip Simple adnexal cyst less than 5 cm in diameter in premenopausal patient Degenerative joint disease of low back
Andere Medikamente
Etonogestrel (NEXPLANON SUBCUT) nystatin (MYCOSTATIN) powder predniSONE (DELTASONE) 50 MG tablet
Allergien
NONE listed historically - after this event Influenza vaccine and COVID (mRNA) vaccine added to list of allergies
Vorherige Impfungen
-

VAERS 1893660

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge n34ck

mild
Staat
FL
Alter
44,0
Geschlecht
M
Eingang
23.11.2021
Impfdatum
19.11.2021
Beginn
19.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fatigue Headache Insomnia Lymphadenopathy Pain Pain in extremity Pyrexia

Symptomtext

I received both vaccines simultaneously on 11/19/2021 shortly after 11 AM. 12 hours later around 11 PM the following symptoms occurred - extensive body aches, fever, headache, fatigue, inability to sleep, sore arms. These symptoms continued for the next two days. Also very noticeable are swollen lymph nodes under both arms. Fatigue continues as of today, 11/23/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
depression
Andere Medikamente
buproprion xl 300 mg
Allergien
none
Vorherige Impfungen
2nd shot of Pfizer covid shot on 04/19/2021

VAERS 1869768

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

mild
Staat
TX
Alter
50,0
Geschlecht
F
Eingang
15.11.2021
Impfdatum
01.11.2021
Beginn
01.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site joint pain

Symptomtext

Pain of right shoulder joint

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site joint pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
essential hypertension, iron deficiency anemia, body mass index 40+ - severely obese, rosacea, reactive thrombocytosis
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1868501

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

mild
Staat
MN
Alter
30,0
Geschlecht
F
Eingang
14.11.2021
Impfdatum
13.11.2021
Beginn
14.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Cough Fatigue Headache Myalgia Nausea Pain in extremity Pyrexia

Symptomtext

Fever, cough, nausea, headache, muscle aches, chills, fatigue, arm soreness. Started during the night 11/14- headache, arm soreness. Started mid-morning- nausea. Started later afternoon- fever, cough, muscle aches, chills, fatigue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Also got influenza vaccine
Allergien
None
Vorherige Impfungen
Fever, cough, nausea, diarrhea, headache, sore throat, congestion, chills, muscle aches, fatigue, age 30, 2/18/2021, COVID moder

VAERS 1850019

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

mild
Staat
NC
Alter
33,0
Geschlecht
F
Eingang
08.11.2021
Impfdatum
05.11.2021
Beginn
06.11.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Night sweats

Symptomtext

Night sweats (three days in a row), arm soreness at injection site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2105686

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge N34CK

gering
Staat
TX
Alter
5,0
Geschlecht
F
Eingang
11.02.2022
Impfdatum
11.02.2022
Beginn
11.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Five year old female child in clinic for Covid-19 and Flu vaccine, Child was mistakenly given 12yrs and up vaccine. She was kept in observation for over 15 minutes nurse and doctors were notified no symptoms developed during observation period and no treatments had to be given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA, food allergies, or other products
Vorherige Impfungen
-